Cargando…

F12. INFLAMMATORY BIOMARKERS AND COGNITION IN FIRST EPISODE PSYCHOSIS: GENDER DIFFERENCES

BACKGROUND: Cognitive impairment is considered a central feature of psychotic disorders, with an important impact on prognosis and functional outcome (Nuechterlein et al., 2011). Among the etiological explanations on psychosis, several hypotheses involving alterations in the immune / inflammatory sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llorca, Bibiana Cabrera, Bioque, Miquel, Mezquida, Gisela, Gonzalez-Pinto, Ana, Parellada, Mara, Bobes, Julio, Lobo, Antonio, García-Bueno, Borja, MacDowell, Karina, Torrent, Carla, Saiz-Martinez, Pilar, Leza, Juan Carlos, Bernardo, Miquel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888205/ http://dx.doi.org/10.1093/schbul/sby017.543

Ejemplares similares

Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis
por: Barcones, Maria Fe, et al.
Publicado: (2017)

The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance
por: Hidalgo-Figueroa, María, et al.
Publicado: (2022)

Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up
por: Hidalgo-Figueroa, Maria, et al.
Publicado: (2023)

Pro-/Antiinflammatory Dysregulation in Early Psychosis: Results from a 1-Year Follow-Up Study
por: García-Bueno, Borja, et al.
Publicado: (2015)

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
por: Bioque, Miquel, et al.
Publicado: (2015)

F245. COGNITIVE RESERVE DIFFERENCE IN AFFECTIVE AND NONAFFECTIVE PSYCHOSIS
por: Amoretti, Silvia, et al.
Publicado: (2018)

The effect of early life events on glucose levels in first-episode psychosis
por: Garcia-Rizo, Clemente, et al.
Publicado: (2022)

S18. STRUCTURAL COVARIANCE PREDICTORS OF CLINICAL IMPROVEMENT AT 2-YEAR FOLLOW-UP IN FIRST-EPISODE PSYCHOSIS
por: Saiz-Masvidal, Cristina, et al.
Publicado: (2020)

The search for new biomarkers for cognition in schizophrenia
por: Penadés, Rafael, et al.
Publicado: (2015)

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year
por: Martinez-Cengotitabengoa, M., et al.
Publicado: (2016)

S229. THE EFFECT OF FAMILY ENVIRONMENT ON LONGITUDINAL FUNCTIONING IN FIRST PSYCHOTIC EPISODES
por: Verdolini, Norma, et al.
Publicado: (2020)

T25. THE RELATIONSHIP BETWEEN AGE AT FIRST-EPISODE AND LONGITUDINAL CORTICAL CHANGES IN FIRST-EPISODE PSYCHOSIS: A TWO-YEAR LONGITUDINAL STUDY IN AN ADOLESCENT AND ADULT-ONSET COHORT
por: Santonja, Javier, et al.
Publicado: (2020)

Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis
por: Solanes, Aleix, et al.
Publicado: (2022)

Epigenetic clocks in relapse after a first episode of schizophrenia
por: Segura, Àlex-González, et al.
Publicado: (2022)

Cortical thinning over two years after first-episode psychosis depends on age of onset
por: Pina-Camacho, Laura, et al.
Publicado: (2022)

Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients
por: Rodríguez, Natalia, et al.
Publicado: (2022)

The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of Psychosis
por: Molina-García, Mariola, et al.
Publicado: (2021)

Cognitive Reserve Assessment Scale in Health (CRASH): Its Validity and Reliability
por: Amoretti, Silvia, et al.
Publicado: (2019)

Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode
por: Segura, Alex G., et al.
Publicado: (2023)

S47. A MULTICENTER STUDY OF COGNITIVE RESERVE IN FIRST-EPISODE PYCHOSIS
por: Amoretti, Silvia, et al.
Publicado: (2020)

Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability – a review
por: González-Rodríguez, Alexandre, et al.
Publicado: (2015)

Association Between Medication Adherence and Oxidative Stress in Patients With First-Episode Mania
por: García, Saínza, et al.
Publicado: (2019)

M60. EARLY VERSUS DELAYED PRESCRIPTION OF CLOZAPINE AND THE COGNITIVE PERFORMANCE ON SCHIZOPHRENIA
por: Amoretti, Silvia, et al.
Publicado: (2020)

Exploring Risk and Resilient Profiles for Functional Impairment and Baseline Predictors in a 2-Year Follow-Up First-Episode Psychosis Cohort Using Latent Class Growth Analysis
por: Salagre, Estela, et al.
Publicado: (2020)

Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology
por: Afia, Amira Ben, et al.
Publicado: (2021)

Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study
por: Bioque, Miquel, et al.
Publicado: (2020)

Paliperidone Prevents Brain Toll-Like Receptor 4 Pathway Activation and Neuroinflammation in Rat Models of Acute and Chronic Restraint Stress
por: MacDowell, KS, et al.
Publicado: (2015)

Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2020)

Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial
por: Dal Santo, Francesco, et al.
Publicado: (2022)

Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways
por: MacDowell, Karina S., et al.
Publicado: (2021)

T14. HYPOTHALAMIC-PITUITARY-GONADAL AXIS HORMONES IN ANTIPSYCHOTIC NAïVE FIRST-EPISODE OF PSYCHOSIS AND HEALTHY CONTROLS
por: Teresa Pons-Cabrera, Maria, et al.
Publicado: (2020)

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History
por: González-Pinto, Ana, et al.
Publicado: (2016)

Effects of the COVID-19 pandemic and lockdown in Spain: comparison between community controls and patients with a psychiatric disorder. Preliminary results from the BRIS-MHC STUDY.
por: Solé, Brisa, et al.
Publicado: (2021)

Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study
por: D'Andrea, Giuseppe, et al.
Publicado: (2023)

The role of genetics in cognitive remediation in schizophrenia: A systematic review
por: Penadés, Rafael, et al.
Publicado: (2019)

Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: a network analysis from the OPTiMiSE trial
por: Dal Santo, F., et al.
Publicado: (2023)

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study
por: Micó, Juan Antonio, et al.
Publicado: (2011)

M192. SENSITIVITY FOR MOTION IS WEAKENED IN FIRST EPISODE PSYCHOSIS
por: Badia, Francina, et al.
Publicado: (2020)

S163. GLUTAMATERGIC METABOLITES IN THE PSYCHOSIS SPECTRUM: FROM HIGH RISK SAMPLES TO FIRST EPISODE PSYCHOSIS
por: Fortea, Adriana, et al.
Publicado: (2020)

The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals
por: Juncal-Ruiz, María, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l0hnpno3qe4mn5g83mqk9s1153